Article
Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
Progress in neuro-psychopharmacology & biological psychiatry - 15 Jun 2009
Tsai Shih-Jen, Hong Chen-Jee, Liou Ying-Jay, Yu Younger W-Y, Chen Tai-Jui, Hou Sheue-Jane, Yen Feng-Chang
Abstract excerpt
Tryptophan hydroxylase-2 (TPH2) is the rate-limiting biosynthetic isoenzyme for serotonin that is preferentially expressed in the brain and has been implicated in the pathogenesis of major depressive disorder (MDD) and in the mechanism of antidepressant action. This study aimed to investigate whether common genetic variation in the TPH2 gene is associated with MDD and therapeutic response to antidepressants in a...
Topics
- Adult
- Antidepressive Agents
- Citalopram
- Depressive Disorder, Major
- Female
- Fluoxetine
- Gene Frequency
- Genetic Predisposition to Disease
- Genotype
- Humans
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Selective Serotonin Reuptake Inhibitors
